{"resourceType":"ValueSet","id":"2.16.840.1.113883.3.464.1003.1146","meta":{"versionId":"7","lastUpdated":"2021-11-02T01:01:56.000-04:00"},"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1146","version":"20211102","name":"Buprenorphine Oral","status":"active","date":"2021-11-02T01:01:56-04:00","publisher":"NCQA PHEMUR","compose":{"include":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","concept":[{"code":"351264","display":"buprenorphine 2 MG Sublingual Tablet"},{"code":"351265","display":"buprenorphine 8 MG Sublingual Tablet"}]}]},"expansion":{"identifier":"urn:uuid:11b53e5a-9f90-41f0-9356-5a5858db0772","timestamp":"2022-06-10T05:14:40-04:00","total":2,"offset":0,"parameter":[{"name":"count","valueInteger":1000},{"name":"offset","valueInteger":0}],"contains":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"351264","display":"buprenorphine 2 MG Sublingual Tablet"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"351265","display":"buprenorphine 8 MG Sublingual Tablet"}]}}